Cargando…
Safety and Efficacy of Bojungikki-Tang in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial
Cancer immunotherapy with immune checkpoint inhibitors (ICIs) is a major treatment option for several types of cancer, including non-small cell lung cancer (NSCLC). The proposed study aims to investigate the safety and efficacy of Bojungikki-tang (BJIKT) therapy (an herbal medicine) in patients with...
Autores principales: | Ko, Mi Mi, Jeong, Mi-Kyung, Choi, Chang Min, Lee, Seung Hyeun, Chun, Jaemoo, Yi, Jin-Mu, Jang, Ho, Lee, Sung Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002386/ https://www.ncbi.nlm.nih.gov/pubmed/36901517 http://dx.doi.org/10.3390/ijerph20054507 |
Ejemplares similares
-
Bojungikki-Tang Improves Response to PD-L1 Immunotherapy by Regulating the Tumor Microenvironment in MC38 Tumor-Bearing Mice
por: Chun, Jaemoo, et al.
Publicado: (2022) -
Evaluation of the potential herb-drug interaction between Bojungikki-tang and PD-L1 immunotherapy in a syngeneic mouse model
por: Yang, Sung-Yoon, et al.
Publicado: (2023) -
Herbal medicine (Bojungikki-tang) for allergic rhinitis: A protocol for a systematic review of controlled trials
por: Lee, Ju Ah, et al.
Publicado: (2018) -
Study of Pharmacodynamic and Pharmacokinetic Interaction of Bojungikki-Tang with Aspirin in Healthy Subjects and Ischemic Stroke Patients
por: Yoo, Jung-Hwa, et al.
Publicado: (2018) -
Differential Regulation of NF-κB and Nrf2 by Bojungikki-Tang Is Associated with Suppressing Lung Inflammation
por: Park, Soo Ryun, et al.
Publicado: (2018)